Bal Pharma

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE083D01012
NSEID: BALPHARMA
BSEID: 524824
View on NSE | View on BSE

INR

87.05

0.7 (0.81%)

BSENSE

Jul 17, 03:30 PM

BSE+NSE Vol: 17.14 k

{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "87.05",
    "chg": 0.7,
    "chgp": "0.81%",
    "dir": 1,
    "prev_price": "86.35",
    "mcapval": "139.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE083D01012",
    "curr_date": "Jul 17, 03:30 PM",
    "curr_time": "06:55 AM",
    "last_traded_at": "Jul 17, 03:30 PM IST",
    "bse_nse_vol": "17.14 k",
    "exc_status": "Active",
    "traded_date": "Jul 17, 2026",
    "traded_date_str": "2026 07 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bal-pharma-555664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma Gains 9.25%: Valuation Shift and Technical Upgrade Drive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-gains-925-valuation-shift-and-technical-upgrade-drive-momentum-4107571",
        "imagepath": "",
        "date": "2026-07-18 17:01:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Jul:</strong> Stock opens at ₹79.31, modest decline amid flat Sensex</p>\n                    <p><strong>14 Jul:</strong> Mojo Grade upgraded to Hold; stock surges 14.61% to ₹90.90</p>\n                    <p><strong>15 Jul:</strong> Valuation improves amid sector volatility; stock dips 3.67% to ₹87.56</p>\n                    <p><strong>16 Jul:</strong> Minor correction with 1.38% decline to ₹86.35</p>\n                    <p><strong>17 Jul:</strong> Week closes at ₹87.05, up 0.81% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.79.68</div></d..."
      },
      {
        "title": "Bal Pharma Ltd Upgraded to Hold as Technicals and Valuation Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-upgraded-to-hold-as-technicals-and-valuation-improve-4103247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BalPharmaLtd_mojoScore_4103247.png",
        "date": "2026-07-15 08:11:59",
        "description": "Bal Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and valuation metrics despite ongoing challenges in financial performance and long-term growth. The upgrade, effective from 14 Jul 2026, is driven primarily by bullish technical trends and a more attractive valuation profile relative to its pharmaceutical peers."
      },
      {
        "title": "Bal Pharma Ltd Valuation Improves as Price Attractiveness Shifts Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-valuation-improves-as-price-attractiveness-shifts-amid-sector-challenges-4102903",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BalPharmaLtd_valuationdot_4102903.png",
        "date": "2026-07-15 08:00:32",
        "description": "Bal Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting improved price appeal relative to its historical averages and peer group. This upgrade comes amid a volatile pharmaceutical sector landscape, where the company’s micro-cap status and recent price surge have drawn investor attention despite mixed longer-term returns."
      },
      {
        "title": "Bal Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-sell-by-marketsmojo-4090710",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BalPharmaLtd_mojoScore_4090710.png",
        "date": "2026-07-06 10:10:05",
        "description": "Bal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance."
      },
      {
        "title": "Bal Pharma Ltd Valuation Shifts to Very Attractive Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-valuation-shifts-to-very-attractive-amid-market-volatility-4077687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BalPharmaLtd_valuationdot_4077687.png",
        "date": "2026-06-30 08:00:52",
        "description": "Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite recent share price declines and a challenging market environment, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a compelling entry point relative to its peers and historical averages."
      },
      {
        "title": "Bal Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-sell-by-marketsmojo-4073135",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BalPharmaLtd_mojoScore_4073135.png",
        "date": "2026-06-25 10:10:38",
        "description": "Bal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bal Pharma Ltd Falls 3.27%: Valuation Appeal Amid Downgrade and Weak Financials",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-327-valuation-appeal-amid-downgrade-and-weak-financials-4052454",
        "imagepath": "",
        "date": "2026-06-13 17:27:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Valuation shifts to very attractive amid market volatility</p>\n                    <p><strong>2 June:</strong> Downgrade to Strong Sell due to weak financial trends and bearish technical outlook</p>\n                    <p><strong>5 June:</strong> Week closes at ₹87.30, down 3.27%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹90.25</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹87.30</div><div class=\"stat-change negative\">-3.27%</div></div>\n                    <div c..."
      },
      {
        "title": "Bal Pharma Ltd’s Mixed Week: -0.69% Price Change Amid Technical Signals and Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltds-mixed-week--069-price-change-amid-technical-signals-and-downgrade-4051428",
        "imagepath": "",
        "date": "2026-06-13 13:06:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 June:</strong> Formation of Golden Cross, signalling potential bullish breakout</p>\n                    <p><strong>9 June:</strong> Downgrade to Sell rating by MarketsMOJO amid weak fundamentals</p>\n                    <p><strong>12 June:</strong> Stock rebounds with a 2.22% gain, closing at Rs.86.70</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.87.30</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.86.70</div><div class=\"stat-change negative\">-0.69%</div></div>\n                ..."
      },
      {
        "title": "Bal Pharma Ltd Downgraded to Sell Amidst Flat Financials and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-downgraded-to-sell-amidst-flat-financials-and-weak-fundamentals-4040452",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BalPharmaLtd_mojoScore_4040452.png",
        "date": "2026-06-09 08:34:19",
        "description": "Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Strong Sell to a Sell rating following a comprehensive review of its financial performance, valuation metrics, and technical indicators. Despite some attractive valuation aspects, the company’s flat quarterly results, weak long-term fundamentals, and deteriorating financial trends have prompted a cautious stance from analysts."
      }
    ],
    "total": 154,
    "sid": "555664",
    "stock_news_url": "https://www.marketsmojo.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jul-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30.06.2026",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "09-Jul-2026",
      "details": "Postal Ballot Notice for consider the issue of 1000000 Warrants to Mr. Shailesh Siroya promoter of the Company on preferential basis",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Jun-2026",
      "details": "Trading window closure for the quarter ended 30.06.2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bal Pharma Gains 9.25%: Valuation Shift and Technical Upgrade Drive Momentum

2026-07-18 17:01:17

Key Events This Week

13 Jul: Stock opens at ₹79.31, modest decline amid flat Sensex

14 Jul: Mojo Grade upgraded to Hold; stock surges 14.61% to ₹90.90

15 Jul: Valuation improves amid sector volatility; stock dips 3.67% to ₹87.56

16 Jul: Minor correction with 1.38% decline to ₹86.35

17 Jul: Week closes at ₹87.05, up 0.81% on the day

Week Open

Rs.79.68

Read full news article

Bal Pharma Ltd Upgraded to Hold as Technicals and Valuation Improve

2026-07-15 08:11:59

Bal Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and valuation metrics despite ongoing challenges in financial performance and long-term growth. The upgrade, effective from 14 Jul 2026, is driven primarily by bullish technical trends and a more attractive valuation profile relative to its pharmaceutical peers.

Read full news article

Bal Pharma Ltd Valuation Improves as Price Attractiveness Shifts Amid Sector Challenges

2026-07-15 08:00:32

Bal Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting improved price appeal relative to its historical averages and peer group. This upgrade comes amid a volatile pharmaceutical sector landscape, where the company’s micro-cap status and recent price surge have drawn investor attention despite mixed longer-term returns.

Read full news article

Bal Pharma Ltd is Rated Sell by MarketsMOJO

2026-07-06 10:10:05

Bal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.

Read full news article

Bal Pharma Ltd Valuation Shifts to Very Attractive Amid Market Volatility

2026-06-30 08:00:52

Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite recent share price declines and a challenging market environment, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a compelling entry point relative to its peers and historical averages.

Read full news article

Bal Pharma Ltd is Rated Sell by MarketsMOJO

2026-06-25 10:10:38

Bal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bal Pharma Ltd Falls 3.27%: Valuation Appeal Amid Downgrade and Weak Financials

2026-06-13 17:27:27

Key Events This Week

1 June: Valuation shifts to very attractive amid market volatility

2 June: Downgrade to Strong Sell due to weak financial trends and bearish technical outlook

5 June: Week closes at ₹87.30, down 3.27%

Read full news article

Bal Pharma Ltd’s Mixed Week: -0.69% Price Change Amid Technical Signals and Downgrade

2026-06-13 13:06:08

Key Events This Week

8 June: Formation of Golden Cross, signalling potential bullish breakout

9 June: Downgrade to Sell rating by MarketsMOJO amid weak fundamentals

12 June: Stock rebounds with a 2.22% gain, closing at Rs.86.70

Read full news article

Bal Pharma Ltd Downgraded to Sell Amidst Flat Financials and Weak Fundamentals

2026-06-09 08:34:19

Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Strong Sell to a Sell rating following a comprehensive review of its financial performance, valuation metrics, and technical indicators. Despite some attractive valuation aspects, the company’s flat quarterly results, weak long-term fundamentals, and deteriorating financial trends have prompted a cautious stance from analysts.